Immunity to glycan α-Gal and possibilities for the control of COVID-19
Résumé
"Despite the advances and potential impact that new vaccines represent for the prevention and control of COVID-19, interventions boosting the immune response to alpha-Gal with a broader and not pathogen-specific immunity may contribute not only to the control of COVID-19 but also to potential re-infections by SARS-CoV-2-related genetic variants or other pathogens that negatively affect the individual response to SARS-CoV-2."